Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
Not Confirmed
Not Confirmed
22-25 April, 2025
AACR Annual meetingAACR Annual meeting
Not Confirmed
Not Confirmed
25-30 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
Industry Trade Show
Not Confirmed
22-25 April, 2025
AACR Annual meetingAACR Annual meeting
Industry Trade Show
Not Confirmed
25-30 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : EPLERENONE
Dosage Strength : 25MG
Packaging :
Approval Date : 2021-10-25
Application Number : 207842
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : EPLERENONE
Dosage Strength : 50MG
Packaging :
Approval Date : 2021-10-25
Application Number : 207842
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : MIGLITOL
Dosage Strength : 50MG
Packaging :
Approval Date : 2015-02-24
Application Number : 203965
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : MIGLITOL
Dosage Strength : 25MG
Packaging :
Approval Date : 2015-02-24
Application Number : 203965
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : MIGLITOL
Dosage Strength : 100MG
Packaging :
Approval Date : 2015-02-24
Application Number : 203965
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET, DELAYED RELEASE;...
Brand Name : POSACONAZOLE
Dosage Strength : 100MG
Packaging :
Approval Date : 2023-06-20
Application Number : 216326
Regulatory Info : RX
Registration Country : USA
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : EPLERENONE
Dosage Strength : 25MG
Approval Date : 2021-10-25
Application Number : 207842
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : EPLERENONE
Dosage Strength : 50MG
Approval Date : 2021-10-25
Application Number : 207842
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : MIGLITOL
Dosage Strength : 25MG
Approval Date : 2015-02-24
Application Number : 203965
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : MIGLITOL
Dosage Strength : 50MG
Approval Date : 2015-02-24
Application Number : 203965
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : MIGLITOL
Dosage Strength : 100MG
Approval Date : 2015-02-24
Application Number : 203965
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Proprietary Name : POSACONAZOLE
Dosage Strength : 100MG
Approval Date : 2023-06-20
Application Number : 216326
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
ABOUT THIS PAGE